To observe the clinical effect of tonifying kidney and reducing turbidity decoction combined with external application of kidney failure umbilical therapy decoction in the treatment of chronic renal failure (CRF).
A total of 70 patients with CRF diagnosed in Shanghai Gongli Hospital of Pudong New Area from March 2023 to December 2024 were selected and randomly divided into a treatment group and a control group, with 35 cases in each group. The control group was given basic Western medical treatment, while the treatment group was treated with oral administration of traditional Chinese medicine combined with umbilical therapy, both groups were treated for 8 weeks.The total effective rate, serum creatinine (Scr), estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), serum uricacid (SUA), interleukin (IL)-6 and hypersensitive C-reactive protein (hs-CRP) were compared between the two groups.
The total effective rate of the treatment group was better than that of the control group (91.43% vs.71.43%, P<0.05). After treatment, the levels of Scr and SUA in the treatment group were lower than those in the control group (P<0.05), and the level of eGFR was higher than that in the control group (P<0.05). There was no significant change in BUN between the two groups (P>0.05). The levels of IL-6 and hs-CRP in both groups were decreased compared with before (P<0.05), and the level of IL-6 in the treatment group was lower than that in the control group (P<0.05). There was no significant difference in the reduction amplitude of hs-CRP levels between the two groups (P>0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05).During the treatment period, no serious adverse events or deterioration of the condition occurred in either group of patients, such as doubling of serum creatinine levels, entering dialysis status, or hospitalization due to heart failure.
The internal and external treatment method of Tonifying Kidney and Reducing Turbidity has a better effect in delaying the deterioration of renal function in CRF with deficiency of both spleen and kidney, and has good safety. Its mechanism of action may be related to the inhibition of inflammatory factors.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |